Safety and Tolerability of Intravenous Lidocaine Infusions as Opioid Adjunct for Children Hospitalized With Sickle Cell Vaso‐Occlusive Pain
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Ugochukwu Agbakwuru und 5 weiteren Autor:innen. Beteiligte Einrichtung: Aflac Cancer and Blood Disorder Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Lidocaine, Analgesics, Opioid, Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: ASH Minority Resident Award.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Sickle cell disease (SCD) vaso‐occlusive episode (VOE) pain is treated with opioids, and non‐opioid adjuvants may reduce pain severity without opioid side effects. We retrospectively investigated the safety and tolerability of intravenous lidocaine infusions as an adjunct to opioids in children and adolescents during VOE hospitalizations. In 2 years, lidocaine was administered in 64.6% of 260 admissions. There were no serious toxicities; overall, 82.2% of recipients chose to receive lidocaine during subsequent admissions. Lidocaine infusions were associated with longer hospitalizations, potentially reflecting selection bias. The efficacy of adjuvant lidocaine infusions during VOE should be studied prospectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aflac Cancer and Blood Disorder Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA.
- Department of Anesthesiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
- Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Monica L Hulbert
Förderung
- ASH Minority Resident Award
Zitieren
APA
Agbakwuru, U., AuBuchon, J. D., Toebe, B., LaBarge, A., Di Paola, J., & Hulbert, M. L. (2025). Safety and Tolerability of Intravenous Lidocaine Infusions as Opioid Adjunct for Children Hospitalized With Sickle Cell Vaso‐Occlusive Pain. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31458
Vancouver
Agbakwuru U, AuBuchon JD, Toebe B, LaBarge A, Di Paola J, Hulbert ML. Safety and Tolerability of Intravenous Lidocaine Infusions as Opioid Adjunct for Children Hospitalized With Sickle Cell Vaso‐Occlusive Pain. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31458
BibTeX
@article{Agbakwuru2025,
author = {Agbakwuru, Ugochukwu and AuBuchon, Jacob D and Toebe, Bobi and LaBarge, Anne and Di Paola, Jorge and Hulbert, Monica L},
title = {Safety and Tolerability of Intravenous Lidocaine Infusions as Opioid Adjunct for Children Hospitalized With Sickle Cell Vaso‐Occlusive Pain},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31458}
}
EUVIMED